[HTML][HTML] Vasoprotective endothelial effects of chronic cannabidiol treatment and its influence on the endocannabinoid system in rats with primary and secondary …

M Baranowska-Kuczko, H Kozłowska, M Kloza… - Pharmaceuticals, 2021 - mdpi.com
Our study aimed to examine the endothelium (vascular)-protecting effects of chronic
cannabidiol (CBD) administration (10 mg/kg once daily for 2 weeks) in aortas and small …

[HTML][HTML] In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats

AJ Wheal, K Jadoon, MD Randall… - Frontiers in …, 2017 - frontiersin.org
Background and purpose: We have shown that in vitro treatment with cannabidiol (CBD, 2 h)
enhances endothelial function in arteries from Zucker diabetic fatty (ZDF) rats, partly due to a …

[HTML][HTML] Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: Modification by hypertension and the potential pharmacological …

M Baranowska-Kuczko, H Kozlowska… - Journal of …, 2020 - journals.lww.com
Objective: Cannabidiol (CBD) has been suggested as a potential antihypertensive drug. The
aim of our study was to investigate its vasodilatory effect in isolated human pulmonary …

[HTML][HTML] Chronic cannabidiol administration fails to diminish blood pressure in rats with primary and secondary hypertension despite its effects on cardiac and plasma …

P Remiszewski, I Jarocka-Karpowicz… - International Journal of …, 2020 - mdpi.com
We investigated the influence of cannabidiol (CBD) on blood pressure (BP) and heart rate
(HR) in spontaneously (SHR) and deoxycorticosterone (DOCA-salt) hypertensive rats …

Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes

CP Stanley, AJ Wheal, MD Randall… - European journal of …, 2013 - Elsevier
Circulating levels of anandamide are increased in diabetes, and cannabidiol ameliorates a
number of pathologies associated with diabetes. The aim of the present study was to …

Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation

CP Stanley, WH Hind, C Tufarelli… - Cardiovascular …, 2015 - academic.oup.com
Aims The protective effects of cannabidiol (CBD) have been widely shown in preclinical
models and have translated into medicines for the treatment of multiple sclerosis and …

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension

S Bátkai, P Pacher, D Osei-Hyiaman, S Radaeva… - Circulation, 2004 - Am Heart Assoc
Background—Endocannabinoids are novel lipid mediators with hypotensive and
cardiodepressor activity. Here, we examined the possible role of the endocannabinergic …

Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation

AJ Wheal, M Cipriano, CJ Fowler, MD Randall… - … of Pharmacology and …, 2014 - ASPET
Cannabidiol (CBD) decreases insulitis, inflammation, neuropathic pain, and myocardial
dysfunction in preclinical models of diabetes. We recently showed that CBD also improves …

Chronic treatment with the cannabinoid 1 antagonist rimonabant altered vasoactive cyclo-oxygenase-derived products on arteries from obese Zucker rats

C Mingorance, MA de Sotomayor… - Journal of …, 2010 - journals.lww.com
To investigate the effect of chronic cannabinoid 1 antagonism on vascular prostanoid
production, obese Zucker rats were treated with rimonabant (10 mg/kg per day) during 20 …

ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BKCa channels, and nitric oxide dependent …

E López-Dyck, F Andrade-Urzúa, A Elizalde… - Pharmacological …, 2017 - Springer
Background Some cannabinoids, a family of compounds derived from Cannabis sativa
(marijuana), have previously shown vasodilator effects in several studies, a feature that …